Medpace (MEDP) a scientifically-driven, global, full-service clinical contract research organization (CRO) known for its strong scientific expertise, announced the addition…
Read More
With the addition of these highly-qualified physicians, Medpace can offer Sponsors even deeper expertise across a broad spectrum of diseases and technologies.
Read More
Medpace (MEDP), a scientifically-driven, global full-service clinical research organization (CRO), has been recognized with five CRO Leadership Awards from Life Science Leader magazine. Now…
Read More
We are delighted to announce our participation in Rare Disease Day for another consecutive year. In addition to our internal activities, Medpace will be hosting a webinar on how advanced therapies are dramatically changing the way patients are treated for a wide variety of diseases – particularly for patients with rare diseases and orphan indications.
Read More
Medpace (MEDP) a scientifically-driven, global, full-service clinical contract research organization (CRO) known for its strong therapeutic and regulatory expertise, announced…
Read More
Medpace (MEDP), a scientifically-driven, global full-service clinical research organization (CRO), has been recognized with six CRO Leadership Awards from Life…
Read More
Medpace (MEDP), a scientifically-driven, global full-service clinical research organization (CRO), was recognized with the first-ever ACRP-Avoca CRO Quality Award on…
Read More
As part of Medpace’s ongoing partnership with the American Heart Association, we are delighted to once again announce our participation in the 2018 Heart Mini Marathon & Walk in downtown Cincinnati on Sunday, March 18th.
Read More
This year, Medpace marks its 25th year as a scientifically-driven, global full-service clinical research organization. A lot has changed in the past 25 years. What hasn’t changed is Medpace’s dedication to the mission of accelerating the global development of safe and effective medical therapeutics. In this post, we visually show how we’ve grown from a small group of dedicated people looking for a better way to conduct clinical research to a publicly held, global community of 2,500 employees across 35 countries.
Read More
Several weeks ago, we announced that Dr. Gregory Hale joined the Medpace medical leadership team. He is an experienced physician with clinical expertise in bone marrow transplantation, cellular therapies, and hematologic malignancies. We were eager to sit down with Dr. Hale to learn more about what attracted him to the Medpace model and what new innovations he is most excited about.
Read More